Chilton Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.8M Buy
397,613
+26,781
+7% +$1.87M 1.01% 38
2025
Q1
$27.3M Buy
370,832
+8,387
+2% +$616K 1.18% 31
2024
Q4
$23.7M Buy
362,445
+12,889
+4% +$844K 1% 34
2024
Q3
$27.2M Buy
349,556
+23,051
+7% +$1.8M 1.13% 28
2024
Q2
$25.5M Sell
326,505
-4,949
-1% -$386K 1.14% 27
2024
Q1
$22.5M Buy
331,454
+9,486
+3% +$643K 1.06% 32
2023
Q4
$21.7M Buy
321,968
+9,607
+3% +$647K 1.1% 36
2023
Q3
$21.2M Buy
312,361
+5,289
+2% +$358K 1.19% 29
2023
Q2
$22M Sell
307,072
-1,847
-0.6% -$132K 1.2% 31
2023
Q1
$21.4M Buy
308,919
+1,813
+0.6% +$126K 1.24% 23
2022
Q4
$20.8M Sell
307,106
-7,524
-2% -$510K 1.3% 24
2022
Q3
$17.3M Buy
314,630
+905
+0.3% +$49.6K 1.15% 30
2022
Q2
$20.7M Sell
313,725
-809
-0.3% -$53.5K 1.26% 26
2022
Q1
$20.9M Sell
314,534
-2,939
-0.9% -$195K 1.09% 34
2021
Q4
$18.5M Buy
317,473
+4,577
+1% +$267K 0.94% 44
2021
Q3
$18.8M Buy
312,896
+9,044
+3% +$543K 1.05% 39
2021
Q2
$18.2M Buy
303,852
+5,215
+2% +$312K 1.05% 42
2021
Q1
$14.8M Buy
298,637
+11,618
+4% +$578K 0.99% 48
2020
Q4
$14.3M Buy
287,019
+3,410
+1% +$170K 1.03% 45
2020
Q3
$15.5M Sell
283,609
-4,491
-2% -$246K 1.21% 29
2020
Q2
$15.2M Buy
288,100
+14,434
+5% +$763K 1.3% 26
2020
Q1
$12.2M Sell
273,666
-7,908
-3% -$353K 1.23% 29
2019
Q4
$14M Sell
281,574
-3,168
-1% -$158K 1.12% 30
2019
Q3
$12.7M Sell
284,742
-1,495
-0.5% -$66.6K 1.05% 41
2019
Q2
$11.8M Buy
286,237
+8,278
+3% +$342K 1.01% 46
2019
Q1
$11.2M Buy
277,959
+90
+0% +$3.64K 0.99% 46
2018
Q4
$10.6M Buy
277,869
+39,919
+17% +$1.52M 1.02% 40
2018
Q3
$9.42M Buy
237,950
+231,856
+3,805% +$9.17M 0.78% 61
2018
Q2
$214K Buy
+6,094
New +$214K 0.02% 205